Paul W. Burridge, Ph.D. - Publications

2015- Pharmacology Northwestern University Medical School, Chicago, IL, United States 
Pharmacogenomics, stem cells, cardiovascular diseases

77 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2024 Fetterman KA, Blancard M, Lyra-Leite DM, Vanoye CG, Fonoudi H, Jouni M, DeKeyser JL, Lenny B, Sapkota Y, George AL, Burridge PW. Independent compartmentalization of functional, metabolic, and transcriptional maturation of hiPSC-derived cardiomyocytes. Cell Reports. 43: 114160. PMID 38678564 DOI: 10.1016/j.celrep.2024.114160  0.816
2024 Fonoudi H, Jouni M, Cejas RB, Magdy T, Blancard M, Ge N, Shah DA, Lyra-Leite DM, Neupane A, Gharib M, Jiang Z, Sapkota Y, Burridge PW. Functional Validation of Doxorubicin-Induced Cardiotoxicity-Related Genes. Jacc. Cardiooncology. 6: 38-50. PMID 38510289 DOI: 10.1016/j.jaccao.2023.11.008  0.762
2023 Chiang DY, Verkerk AO, Victorio R, Shneyer BI, van der Vaart B, Jouni M, Narendran N, Kc A, Sampognaro JR, Vetrano-Olsen F, Oh JS, Buys E, de Jonge B, Shah DA, Kiviniemi T, ... Burridge PW, et al. The Role of and Microtubules in Maintaining Normal Ventricular Conduction. Circulation Research. PMID 38095085 DOI: 10.1161/CIRCRESAHA.123.323231  0.709
2023 Cejas RB, Petrykey K, Sapkota Y, Burridge PW. Anthracycline Toxicity: Light at the End of the Tunnel? Annual Review of Pharmacology and Toxicology. PMID 37788492 DOI: 10.1146/annurev-pharmtox-022823-035521  0.346
2023 Singh P, Shah DA, Jouni M, Cejas RB, Crossman DK, Magdy T, Qiu S, Wang X, Zhou L, Sharafeldin N, Hageman L, McKenna DE, Armenian SH, Balis FM, Hawkins DS, ... ... Burridge PW, et al. Altered Peripheral Blood Gene Expression in Childhood Cancer Survivors With Anthracycline-Induced Cardiomyopathy - A COG-ALTE03N1 Report. Journal of the American Heart Association. e029954. PMID 37750583 DOI: 10.1161/JAHA.123.029954  0.761
2023 Arzt M, Gao B, Mozneb M, Pohlman S, Cejas RB, Liu Q, Huang F, Yu C, Zhang Y, Fan X, Jenkins A, Giuliano AE, Burridge PW, Cui X, Sharma A. Protein-encapsulated doxorubicin reduces cardiotoxicity in hiPSC-cardiomyocytes and cardiac spheroids while maintaining anticancer efficacy. Stem Cell Reports. PMID 37657447 DOI: 10.1016/j.stemcr.2023.08.005  0.414
2023 Singh P, Zhou L, Shah DA, Cejas RB, Crossman DK, Jouni M, Magdy T, Wang X, Sharafeldin N, Hageman L, McKenna DE, Horvath S, Armenian SH, Balis FM, Hawkins DS, ... ... Burridge PW, et al. Identification of novel hypermethylated or hypomethylated CpG sites and genes associated with anthracycline-induced cardiomyopathy. Scientific Reports. 13: 12683. PMID 37542143 DOI: 10.1038/s41598-023-39357-2  0.732
2023 Romero-Tejeda M, Fonoudi H, Weddle CJ, DeKeyser JM, Lenny B, Fetterman KA, Magdy T, Sapkota Y, Epting C, Burridge PW. A novel transcription factor combination for direct reprogramming to a spontaneously contracting human cardiomyocyte-like state. Journal of Molecular and Cellular Cardiology. PMID 37421991 DOI: 10.1016/j.yjmcc.2023.06.005  0.779
2023 Lyra-Leite DM, Copley RR, Freeman PP, Pongpamorn P, Shah D, McKenna DE, Lenny B, Pinheiro EA, Weddle CJ, Gharib M, Javed H, Fonoudi H, Sapkota Y, Burridge PW. Nutritional requirements of human induced pluripotent stem cells. Stem Cell Reports. 18: 1371-1387. PMID 37315525 DOI: 10.1016/j.stemcr.2023.05.004  0.82
2023 Romero-Tejeda M, Fonoudi H, Weddle CJ, DeKeyser JM, Lenny B, Fetterman KA, Magdy T, Sapkota Y, Epting C, Burridge PW. A Novel Transcription Factor Combination for Direct Reprogramming to a Spontaneously Contracting Human Cardiomyocyte-like State. Biorxiv : the Preprint Server For Biology. PMID 36993577 DOI: 10.1101/2023.03.14.532629  0.78
2022 Lyra-Leite DM, Gutiérrez-Gutiérrez Ó, Wang M, Zhou Y, Cyganek L, Burridge PW. A review of protocols for human iPSC culture, cardiac differentiation, subtype-specification, maturation, and direct reprogramming. Star Protocols. 3: 101560. PMID 36035804 DOI: 10.1016/j.xpro.2022.101560  0.816
2022 Barc J, Tadros R, Glinge C, Chiang DY, Jouni M, Simonet F, Jurgens SJ, Baudic M, Nicastro M, Potet F, Offerhaus JA, Walsh R, Choi SH, Verkerk AO, Mizusawa Y, ... ... Burridge PW, et al. Author Correction: Genome-wide association analyses identify new Brugada syndrome risk loci and highlight a new mechanism of sodium channel regulation in disease susceptibility. Nature Genetics. PMID 35474365 DOI: 10.1038/s41588-022-01079-y  0.712
2022 Barc J, Tadros R, Glinge C, Chiang DY, Jouni M, Simonet F, Jurgens SJ, Baudic M, Nicastro M, Potet F, Offerhaus JA, Walsh R, Choi SH, Verkerk AO, Mizusawa Y, ... ... Burridge PW, et al. Genome-wide association analyses identify new Brugada syndrome risk loci and highlight a new mechanism of sodium channel regulation in disease susceptibility. Nature Genetics. PMID 35210625 DOI: 10.1038/s41588-021-01007-6  0.738
2021 Magdy T, Jouni M, Kuo HH, Weddle CJ, Lyra-Leite D, Fonoudi H, Romero-Tejeda M, Gharib M, Javed H, Fajardo G, Ross CJD, Carleton BC, Bernstein D, Burridge PW. Identification of Drug Transporter Genomic Variants and Inhibitors that Protect Against Doxorubicin-Induced Cardiotoxicity. Circulation. PMID 34874743 DOI: 10.1161/CIRCULATIONAHA.121.055801  0.808
2021 Magdy T, Jiang Z, Jouni M, Fonoudi H, Lyra-Leite D, Jung G, Romero-Tejeda M, Kuo HH, Fetterman KA, Gharib M, Burmeister BT, Zhao M, Sapkota Y, Ross CJ, Carleton BC, ... ... Burridge PW, et al. RARG variant predictive of doxorubicin-induced cardiotoxicity identifies a cardioprotective therapy. Cell Stem Cell. PMID 34525346 DOI: 10.1016/j.stem.2021.08.006  0.802
2021 Marchal GA, Jouni M, Chiang DY, Pérez-Hernández Duran M, Podliesna S, Yu N, Casini S, Potet F, Veerman CC, Klerk M, Lodder EM, Mengarelli I, Guan K, Vanoye CG, Rothenberg E, ... ... Burridge P, et al. Targeting the Microtubule EB1-CLASP2 Complex Modulates Na1.5 at Intercalated Discs. Circulation Research. PMID 34092082 DOI: 10.1161/CIRCRESAHA.120.318643  0.748
2021 Lyra-Leite DM, Fonoudi H, Gharib M, Burridge PW. An updated protocol for the cost-effective and weekend-free culture of human induced pluripotent stem cells. Star Protocols. 2: 100213. PMID 33786455 DOI: 10.1016/j.xpro.2020.100213  0.789
2021 Magdy T, Burridge PW. Use of hiPSC to explicate genomic predisposition to anthracycline-induced cardiotoxicity. Pharmacogenomics. 22: 41-54. PMID 33448871 DOI: 10.2217/pgs-2020-0104  0.395
2021 Fonoudi H, Lyra-Leite DM, Javed HA, Burridge PW. Generating a Cost-Effective, Weekend-Free Chemically Defined Human Induced Pluripotent Stem Cell (hiPSC) Culture Medium. Current Protocols in Stem Cell Biology. 53: e110. PMID 32463953 DOI: 10.1002/Cpsc.110  0.822
2021 Magdy T, Burridge PW. Use of hiPSC to explicate genomic predisposition to anthracycline-induced cardiotoxicity Pharmacogenomics. 22: 41-54. DOI: 10.2217/pgs-2020-0104  0.395
2020 Pérez-Hernández Duran M, Leo-Macias A, Keegan S, Jouni M, Kim JC, Agullo-Pascual E, Vermij SH, Zhang M, Liang FX, Burridge P, Fenyo D, Rothenberg E, Delmar M. Structural and Functional Characterization of A Nav1.5-Mitochondrial Couplon. Circulation Research. PMID 33342222 DOI: 10.1161/CIRCRESAHA.120.318239  0.726
2020 Fonoudi H, Burridge PW. Cellular model systems to study cardiovascular injury from chemotherapy. Journal of Thrombosis and Thrombolysis. 51: 890-896. PMID 33051807 DOI: 10.1007/s11239-020-02299-x  0.759
2020 Potet F, Egecioglu DE, Burridge PW, George AL. . Molecular Pharmacology. PMID 32938719 DOI: 10.1124/Molpharm.120.000048  0.434
2020 Burridge PW, Thorp EB. Doxorubicin-Induced Ascension of Resident Cardiac Macrophages. Circulation Research. 127: 628-630. PMID 32790526 DOI: 10.1161/Circresaha.120.317626  0.308
2020 Dainis A, Zaleta-Rivera K, Ribeiro A, Chang ACH, Shang C, Lan F, Burridge PW, Liu WR, Wu JC, Chang ACY, Pruitt BL, Wheeler M, Ashley EA. Silencing of MYH7 ameliorates disease phenotypes in human iPSC-Cardiomyocytes. Physiological Genomics. PMID 32567507 DOI: 10.1152/Physiolgenomics.00021.2020  0.686
2020 Lyra-Leite DM, Burridge PW. Pluripotent Stem Cell Modeling of Anticancer Therapy-Induced Cardiotoxicity. Current Cardiology Reports. 22: 56. PMID 32562096 DOI: 10.1007/S11886-020-01325-X  0.807
2020 Pinheiro EA, Magdy T, Burridge PW. Human In Vitro Models for Assessing the Genomic Basis of Chemotherapy-Induced Cardiovascular Toxicity. Journal of Cardiovascular Translational Research. 13: 377-389. PMID 32078739 DOI: 10.1007/S12265-020-09962-X  0.433
2020 Kuo HH, Gao X, DeKeyser JM, Fetterman KA, Pinheiro EA, Weddle CJ, Fonoudi H, Orman MV, Romero-Tejeda M, Jouni M, Blancard M, Magdy T, Epting CL, George AL, Burridge PW. Negligible-Cost and Weekend-Free Chemically Defined Human iPSC Culture. Stem Cell Reports. PMID 31928950 DOI: 10.1016/J.Stemcr.2019.12.007  0.81
2020 Sapkota Y, Qin N, Ehrhardt MJ, Wang Z, Wilson CL, Estepp J, Rai P, Hankins JE, Burridge P, Jefferies JL, Zhang J, Hudson MM, Robison LL, Armstrong GT, Mulrooney DA, et al. Cardiomyopathy risk among childhood cancer survivors of African ancestry and its molecular mechanisms. Journal of Clinical Oncology. 38: 10514-10514. DOI: 10.1200/Jco.2020.38.15_Suppl.10514  0.336
2020 Lyra Leite DM, Burridge PW. Abstract 534: Chemically Defined Cell Culture Media for High Yield Differentiation of Functional Human Cardiac Myocytes Circulation Research. 127. DOI: 10.1161/res.127.suppl_1.534  0.359
2020 Fonoudi H, Wilcox J, Burridge PW. Abstract 251: Modeling LMNA Associated Cardiomyopathy Using Patient-Specific Human Induced Pluripotent Stem Cells Circulation Research. 127. DOI: 10.1161/res.127.suppl_1.251  0.761
2019 Gintant G, Burridge P, Gepstein L, Harding S, Herron T, Hong C, Jalife J, Wu JC. Use of Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes in Preclinical Cancer Drug Cardiotoxicity Testing: A Scientific Statement From the American Heart Association. Circulation Research. RES0000000000000291. PMID 31533542 DOI: 10.1161/Res.0000000000000291  0.609
2019 Pinheiro EA, Fetterman KA, Burridge PW. hiPSCs in cardio-oncology: deciphering the genomics. Cardiovascular Research. 115: 935-948. PMID 30689737 DOI: 10.1093/Cvr/Cvz018  0.403
2019 Waas M, Weerasekera R, Kropp EM, Romero-Tejeda M, Poon EN, Boheler KR, Burridge PW, Gundry RL. Are These Cardiomyocytes? Protocol Development Reveals Impact of Sample Preparation on the Accuracy of Identifying Cardiomyocytes by Flow Cytometry. Stem Cell Reports. PMID 30686762 DOI: 10.1016/J.Stemcr.2018.12.016  0.408
2019 Bernstein D, Burridge P. Patient-Specific Pluripotent Stem Cells in Doxorubicin Cardiotoxicity: A New Window Into Personalized Medicine. Progress in Pediatric Cardiology. 37: 23-27. PMID 25530693 DOI: 10.1016/j.ppedcard.2014.10.006  0.33
2019 Singh P, Wang X, Hageman L, Chen Y, Magdy T, Landier W, Ginsberg JP, Neglia JP, Sklar CA, Castellino SM, Dreyer ZE, Hudson MM, Robison LL, Blanco JG, Relling MV, ... Burridge P, et al. A novel association between GSTM1 null variant and anthracycline-induced cardiac dysfunction (ACD) in childhood cancer survivors (CCS): A COG ALTE03N1 report. Journal of Clinical Oncology. 37: 10030-10030. DOI: 10.1200/Jco.2019.37.15_Suppl.10030  0.352
2018 Sharma A, McKeithan WL, Serrano R, Kitani T, Burridge PW, Del Álamo JC, Mercola M, Wu JC. Use of human induced pluripotent stem cell-derived cardiomyocytes to assess drug cardiotoxicity. Nature Protocols. PMID 30413796 DOI: 10.1038/S41596-018-0076-8  0.804
2018 Sharma A, Zhang Y, Buikema JW, Serpooshan V, Chirikian O, Kosaric N, Churko JM, Dzilic E, Shieh A, Burridge PW, Wu JC, Wu SM. Stage-specific Effects of Bioactive Lipids on Human iPSC Cardiac Differentiation and Cardiomyocyte Proliferation. Scientific Reports. 8: 6618. PMID 29700394 DOI: 10.1038/S41598-018-24954-3  0.766
2018 Waas M, Weerasekera R, Kropp EM, Romero M, Poon E, Boheler KR, Burridge PW, Gundry RL. Abstract 346: A Standard Flow Cytometry Protocol for Assessing Human Pluripotent Stem Cell-derived Cardiomyocyte Identity by Troponin Positivity Circulation Research. 123. DOI: 10.1161/Res.123.Suppl_1.346  0.451
2017 Lin ZC, McGuire AF, Burridge PW, Matsa E, Lou HY, Wu JC, Cui B. Accurate nanoelectrode recording of human pluripotent stem cell-derived cardiomyocytes for assaying drugs and modeling disease. Microsystems & Nanoengineering. 3: 16080. PMID 31057850 DOI: 10.1038/Micronano.2016.80  0.613
2017 Abilez OJ, Tzatzalos E, Yang H, Zhao MT, Jung G, Zöllner AM, Tiburcy M, Riegler J, Matsa E, Shukla P, Zhuge Y, Chour T, Chen VC, Burridge PW, Karakikes I, et al. Passive Stretch Induces Structural and Functional Maturation of Engineered Heart Muscle as Predicted by Computational Modeling. Stem Cells (Dayton, Ohio). PMID 29086457 DOI: 10.1002/Stem.2732  0.812
2017 Magdy T, Schuldt AJT, Wu JC, Bernstein D, Burridge PW. Human Induced Pluripotent Stem Cell (hiPSC)-Derived Cells to Assess Drug Cardiotoxicity: Opportunities and Problems. Annual Review of Pharmacology and Toxicology. PMID 28992430 DOI: 10.1146/Annurev-Pharmtox-010617-053110  0.571
2017 Flevaris P, Khan SS, Eren M, Schuldt AJ, Shah SJ, Lee DC, Gupta S, Shapiro A, Burridge P, Ghosh AK, Vaughan DE. PAI-1 Controls Cardiomyocyte TGF-β and Cardiac Fibrosis. Circulation. PMID 28588076 DOI: 10.1161/Circulationaha.117.028145  0.33
2017 Sharma A, Burridge PW, McKeithan WL, Serrano R, Shukla P, Sayed N, Churko JM, Kitani T, Wu H, Holmström A, Matsa E, Zhang Y, Kumar A, Fan AC, Del Álamo JC, et al. High-throughput screening of tyrosine kinase inhibitor cardiotoxicity with human induced pluripotent stem cells. Science Translational Medicine. 9. PMID 28202772 DOI: 10.1126/Scitranslmed.Aaf2584  0.802
2016 Magdy T, Burmeister BT, Burridge PW. Validating the pharmacogenomics of chemotherapy-induced cardiotoxicity: What is missing? Pharmacology & Therapeutics. 168: 113-125. PMID 27609196 DOI: 10.1016/J.Pharmthera.2016.09.009  0.463
2016 Matsa E, Burridge PW, Yu KH, Ahrens JH, Termglinchan V, Wu H, Liu C, Shukla P, Sayed N, Churko JM, Shao N, Woo NA, Chao AS, Gold JD, Karakikes I, et al. Transcriptome Profiling of Patient-Specific Human iPSC-Cardiomyocytes Predicts Individual Drug Safety and Efficacy Responses In Vitro. Cell Stem Cell. PMID 27545504 DOI: 10.1016/J.Stem.2016.07.006  0.802
2016 Burridge PW, Li YF, Matsa E, Wu H, Ong SG, Sharma A, Holmström A, Chang AC, Coronado MJ, Ebert AD, Knowles JW, Telli ML, Witteles RM, Blau HM, Bernstein D, et al. Human induced pluripotent stem cell-derived cardiomyocytes recapitulate the predilection of breast cancer patients to doxorubicin-induced cardiotoxicity. Nature Medicine. PMID 27089514 DOI: 10.1038/Nm.4087  0.821
2015 Burridge PW, Sharma A, Wu JC. Genetic and Epigenetic Regulation of Human Cardiac Reprogramming and Differentiation in Regenerative Medicine. Annual Review of Genetics. 49: 461-84. PMID 26631515 DOI: 10.1146/Annurev-Genet-112414-054911  0.617
2015 Burridge PW, Holmström A, Wu JC. Chemically Defined Culture and Cardiomyocyte Differentiation of Human Pluripotent Stem Cells. Current Protocols in Human Genetics / Editorial Board, Jonathan L. Haines ... [Et Al.]. 87: 21.3.1-21.3.15. PMID 26439715 DOI: 10.1002/0471142905.Hg2103S87  0.614
2015 Sharma A, Li G, Rajarajan K, Hamaguchi R, Burridge PW, Wu SM. Derivation of highly purified cardiomyocytes from human induced pluripotent stem cells using small molecule-modulated differentiation and subsequent glucose starvation. Journal of Visualized Experiments : Jove. PMID 25867738 DOI: 10.3791/52628  0.552
2015 Burridge PW, Diecke S, Matsa E, Sharma A, Wu H, Wu JC. Modeling Cardiovascular Diseases with Patient-Specific Human Pluripotent Stem Cell-Derived Cardiomyocytes. Methods in Molecular Biology (Clifton, N.J.). PMID 25690476 DOI: 10.1007/7651_2015_196  0.771
2015 Diecke S, Lu J, Lee J, Termglinchan V, Kooreman NG, Burridge PW, Ebert AD, Churko JM, Sharma A, Kay MA, Wu JC. Novel codon-optimized mini-intronic plasmid for efficient, inexpensive, and xeno-free induction of pluripotency. Scientific Reports. 5: 8081. PMID 25628230 DOI: 10.1038/Srep08081  0.81
2015 Gu M, Mordwinkin NM, Kooreman NG, Lee J, Wu H, Hu S, Churko JM, Diecke S, Burridge PW, He C, Barron FE, Ong SG, Gold JD, Wu JC. Pravastatin reverses obesity-induced dysfunction of induced pluripotent stem cell-derived endothelial cells via a nitric oxide-dependent mechanism. European Heart Journal. 36: 806-16. PMID 25368203 DOI: 10.1093/Eurheartj/Ehu411  0.776
2014 Burridge PW, Metzler SA, Nakayama KH, Abilez OJ, Simmons CS, Bruce MA, Matsuura Y, Kim P, Wu JC, Butte M, Huang NF, Yang PC. Multi-cellular interactions sustain long-term contractility of human pluripotent stem cell-derived cardiomyocytes. American Journal of Translational Research. 6: 724-35. PMID 25628783  0.542
2014 Bhattacharya S, Burridge PW, Kropp EM, Chuppa SL, Kwok WM, Wu JC, Boheler KR, Gundry RL. High efficiency differentiation of human pluripotent stem cells to cardiomyocytes and characterization by flow cytometry. Journal of Visualized Experiments : Jove. 52010. PMID 25286293 DOI: 10.3791/52010  0.62
2014 Ebert AD, Kodo K, Liang P, Wu H, Huber BC, Riegler J, Churko J, Lee J, de Almeida P, Lan F, Diecke S, Burridge PW, Gold JD, Mochly-Rosen D, Wu JC. Characterization of the molecular mechanisms underlying increased ischemic damage in the aldehyde dehydrogenase 2 genetic polymorphism using a human induced pluripotent stem cell model system. Science Translational Medicine. 6: 255ra130. PMID 25253673 DOI: 10.1126/Scitranslmed.3009027  0.791
2014 Boheler KR, Bhattacharya S, Kropp EM, Chuppa S, Riordon DR, Bausch-Fluck D, Burridge PW, Wu JC, Wersto RP, Chan GC, Rao S, Wollscheid B, Gundry RL. A human pluripotent stem cell surface N-glycoproteome resource reveals markers, extracellular epitopes, and drug targets. Stem Cell Reports. 3: 185-203. PMID 25068131 DOI: 10.1016/J.Stemcr.2014.05.002  0.585
2014 Mahairaki V, Ryu J, Peters A, Chang Q, Li T, Park TS, Burridge PW, Talbot CC, Asnaghi L, Martin LJ, Zambidis ET, Koliatsos VE. Induced pluripotent stem cells from familial Alzheimer's disease patients differentiate into mature neurons with amyloidogenic properties. Stem Cells and Development. 23: 2996-3010. PMID 25027006 DOI: 10.1089/Scd.2013.0511  0.677
2014 Sharma A, Marceau C, Hamaguchi R, Burridge PW, Rajarajan K, Churko JM, Wu H, Sallam KI, Matsa E, Sturzu AC, Che Y, Ebert A, Diecke S, Liang P, Red-Horse K, et al. Human induced pluripotent stem cell-derived cardiomyocytes as an in vitro model for coxsackievirus B3-induced myocarditis and antiviral drug screening platform. Circulation Research. 115: 556-66. PMID 25015077 DOI: 10.1161/Circresaha.115.303810  0.804
2014 Burridge PW, Matsa E, Shukla P, Lin ZC, Churko JM, Ebert AD, Lan F, Diecke S, Huber B, Mordwinkin NM, Plews JR, Abilez OJ, Cui B, Gold JD, Wu JC. Chemically defined generation of human cardiomyocytes. Nature Methods. 11: 855-60. PMID 24930130 DOI: 10.1038/Nmeth.2999  0.829
2014 Matsa E, Burridge PW, Wu JC. Human stem cells for modeling heart disease and for drug discovery. Science Translational Medicine. 6: 239ps6. PMID 24898747 DOI: 10.1126/Scitranslmed.3008921  0.597
2014 Bernstein D, Burridge P. Patient-specific pluripotent stem cells in doxorubicin cardiotoxicity: A new window into personalized medicine Progress in Pediatric Cardiology. 37: 23-27. DOI: 10.1016/J.Ppedcard.2014.10.006  0.537
2013 Navarrete EG, Liang P, Lan F, Sanchez-Freire V, Simmons C, Gong T, Sharma A, Burridge PW, Patlolla B, Lee AS, Wu H, Beygui RE, Wu SM, Robbins RC, Bers DM, et al. Screening drug-induced arrhythmia [corrected] using human induced pluripotent stem cell-derived cardiomyocytes and low-impedance microelectrode arrays. Circulation. 128: S3-13. PMID 24030418 DOI: 10.1161/Circulationaha.112.000570  0.819
2013 Churko JM, Burridge PW, Wu JC. Generation of human iPSCs from human peripheral blood mononuclear cells using non-integrative Sendai virus in chemically defined conditions. Methods in Molecular Biology (Clifton, N.J.). 1036: 81-8. PMID 23807788 DOI: 10.1007/978-1-62703-511-8_7  0.792
2013 Burridge PW, Zambidis ET. Highly efficient directed differentiation of human induced pluripotent stem cells into cardiomyocytes. Methods in Molecular Biology (Clifton, N.J.). 997: 149-61. PMID 23546754 DOI: 10.1007/978-1-62703-348-0_12  0.777
2013 Mordwinkin NM, Burridge PW, Wu JC. A review of human pluripotent stem cell-derived cardiomyocytes for high-throughput drug discovery, cardiotoxicity screening, and publication standards. Journal of Cardiovascular Translational Research. 6: 22-30. PMID 23229562 DOI: 10.1007/S12265-012-9423-2  0.617
2013 Hu S, Wilson KD, Ghosh Z, Han L, Wang Y, Lan F, Ransohoff KJ, Burridge P, Wu JC. MicroRNA-302 increases reprogramming efficiency via repression of NR2F2. Stem Cells (Dayton, Ohio). 31: 259-68. PMID 23136034 DOI: 10.1002/Stem.1278  0.782
2012 Thompson SA, Burridge PW, Lipke EA, Shamblott M, Zambidis ET, Tung L. Engraftment of human embryonic stem cell derived cardiomyocytes improves conduction in an arrhythmogenic in vitro model. Journal of Molecular and Cellular Cardiology. 53: 15-23. PMID 22713758 DOI: 10.1016/J.Yjmcc.2012.01.023  0.687
2012 Gu E, Chen WY, Gu J, Burridge P, Wu JC. Molecular imaging of stem cells: tracking survival, biodistribution, tumorigenicity, and immunogenicity. Theranostics. 2: 335-45. PMID 22509197 DOI: 10.7150/Thno.3666  0.583
2012 Burridge PW, Keller G, Gold JD, Wu JC. Production of de novo cardiomyocytes: human pluripotent stem cell differentiation and direct reprogramming. Cell Stem Cell. 10: 16-28. PMID 22226352 DOI: 10.1016/J.Stem.2011.12.013  0.633
2011 Gundry RL, Burridge PW, Boheler KR. Pluripotent stem cell heterogeneity and the evolving role of proteomic technologies in stem cell biology. Proteomics. 11: 3947-61. PMID 21834136 DOI: 10.1002/Pmic.201100100  0.477
2011 Burridge PW, Thompson S, Millrod MA, Weinberg S, Yuan X, Peters A, Mahairaki V, Koliatsos VE, Tung L, Zambidis ET. A universal system for highly efficient cardiac differentiation of human induced pluripotent stem cells that eliminates interline variability. Plos One. 6: e18293. PMID 21494607 DOI: 10.1371/Journal.Pone.0018293  0.759
2010 Peters A, Burridge PW, Pryzhkova MV, Levine MA, Park TS, Roxbury C, Yuan X, Péault B, Zambidis ET. Challenges and strategies for generating therapeutic patient-specific hemangioblasts and hematopoietic stem cells from human pluripotent stem cells. The International Journal of Developmental Biology. 54: 965-90. PMID 20563986 DOI: 10.1387/Ijdb.093043Ap  0.752
2010 Priddle H, Allegrucci C, Burridge P, Munoz M, Smith NM, Devlin L, Sjoblom C, Chamberlain S, Watson S, Young LE, Denning C. Derivation and characterisation of the human embryonic stem cell lines, NOTT1 and NOTT2. In Vitro Cellular & Developmental Biology. Animal. 46: 367-75. PMID 20177995 DOI: 10.1007/S11626-010-9290-6  0.794
2007 Burridge PW, Anderson D, Priddle H, Barbadillo Muñoz MD, Chamberlain S, Allegrucci C, Young LE, Denning C. Improved human embryonic stem cell embryoid body homogeneity and cardiomyocyte differentiation from a novel V-96 plate aggregation system highlights interline variability. Stem Cells (Dayton, Ohio). 25: 929-38. PMID 17185609 DOI: 10.1634/Stemcells.2006-0598  0.76
2006 Priddle H, Jones DR, Burridge PW, Patient R. Hematopoiesis from human embryonic stem cells: overcoming the immune barrier in stem cell therapies. Stem Cells (Dayton, Ohio). 24: 815-24. PMID 16306149 DOI: 10.1634/Stemcells.2005-0356  0.705
2005 Allegrucci C, Denning CN, Burridge P, Steele W, Sinclair KD, Young LE. Human embryonic stem cells as a model for nutritional programming: an evaluation. Reproductive Toxicology (Elmsford, N.Y.). 20: 353-67. PMID 15975761 DOI: 10.1016/J.Reprotox.2005.04.010  0.778
Show low-probability matches.